These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 13525450

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Use of drugs in psychodynamic investigations.
    CATTELL JP.
    Proc Annu Meet Am Psychopathol Assoc; ; ():218-35. PubMed ID: 13441672
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Mescaline and lysergic acid diethylamide: therapeutic implications of the drug-induced state.
    Denber HC.
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:23-7. PubMed ID: 5775311
    [No Abstract] [Full Text] [Related]

  • 29. Clinical and experimental aspects of psychedelic drugs.
    Shoemaker TE.
    J Med Soc N J; 1968 Nov; 65(11):592-4. PubMed ID: 5247200
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Psychodynamics of LSD hallucinations and their bearing on individual psychotherapy.
    Hausner M, Dolezal V.
    Act Nerv Super (Praha); 1965 Aug; 7(3):308-9. PubMed ID: 5882138
    [No Abstract] [Full Text] [Related]

  • 32. The experimental use of psychedelic (LSD) psychotherapy.
    Pahnke WN, Kurland AA, Unger S, Savage C, Grof S.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):446-54. PubMed ID: 5566727
    [No Abstract] [Full Text] [Related]

  • 33. LSD, suggestion and hypnosis.
    Solursh LP, Rae JM.
    Int J Neuropsychiatry; 1966 Feb; 2(1):60-4. PubMed ID: 5907815
    [No Abstract] [Full Text] [Related]

  • 34. [Problems in psychotherapy].
    Booij J.
    Ned Tijdschr Geneeskd; 1968 Sep 14; 112(37):1621-4. PubMed ID: 4878451
    [No Abstract] [Full Text] [Related]

  • 35. Lysergic acid diethylamide. Adverse reactions and use in experimental therapy.
    Keeler MH.
    N C Med J; 1967 Aug 14; 28(8):323-7. PubMed ID: 5235564
    [No Abstract] [Full Text] [Related]

  • 36. [Drug psychiatry].
    BOOIJ J.
    Ned Tijdschr Geneeskd; 1957 Oct 05; 101(40):1869-72. PubMed ID: 13493641
    [No Abstract] [Full Text] [Related]

  • 37. [Mescaline, lysergic acid diethylamide (LSD 25) & menstruation].
    SALERNO EV, TALLAFERRO A.
    Sem Med; 1957 Jan 10; 110(2):47-8; passim. PubMed ID: 13421863
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Permissive group therapy with lysergic acid diethylamide.
    SPENCER AM.
    Br J Psychiatry; 1963 Jan 10; 109():37-45. PubMed ID: 13990011
    [No Abstract] [Full Text] [Related]

  • 40. Therapeutic trial of lysergic Acid diethylamide (LSD) and thioridazine in chronic schizophrenia.
    Shirvaikar RV, Kelkar YW.
    Neurol India; 1966 Jan 10; 14(2):97-101. PubMed ID: 5330728
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.